About / Media Center
Trinity Press Releases
Filter by Type:
TRINITY LIFE SCIENCES UNVEILS INDUSTRY IMPACT SERIES TO SUPPORT LIFE SCIENCES EXECUTIVES ON CRITICAL DECISION MAKING
“Picking Winners: Portfolio Management for a New Era” White Paper Now Available Waltham, MA, April 3, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, unveils its Industry Impact Series—a thought leadership series designed to identify key issues that...
TRINITY LIFE SCIENCES REVEALS SIX KEY GLOBAL MARKET ACCESS TRENDS THAT LIFE SCIENCES COMPANIES NEED TO BE MONITORING
“Annual State of Global Market Access” White Paper Now Available An Upcoming Webinar Entitled “Annual State of Global Market Access” Will Review Findings Waltham, MA, March 26, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability...
TRINITY LIFE SCIENCES LAUNCHES BRAND INSIGHTS AI
Waltham, MA, February 28, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts with deep...
TRINITY LIFE SCIENCES EVALUATES COMMERCIAL PERFORMANCE OVER 3 YEARS OF 58 NOVEL DRUGS APPROVED IN 2020
Waltham, MA, February 13, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Trinity Annual Drug Index white paper, an evaluation of the commercial performances over three years of 58 novel drugs...
CHINA’S 2022 NRDL UPDATE DEMONSTRATES PROMISING PRICING AND ACCESS OPPORTUNITIES FOR INNOVATIVE DRUGS WITH SIGNIFICANT CLINICAL BENEFIT
New White Paper “2022 NRDL Pricing Implementation and Access Outcomes in China” Available Now from Trinity Life Sciences Waltham, MA, December 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that China’s 2022 National Reimbursement...
TRINITY LIFE SCIENCES INSTITUTES A FORMAL CELL AND GENE THERAPY CENTER OF EXCELLENCE
COE Provides Deep Strategic Expertise and Analytical Capabilities to Support Cell and Gene Therapy Organizations Across the Value Chain New White Paper “Empowering Cancer Immunotherapy: Unleashing the Potential of NK Cell Therapies in Oncology” Delivers Overarching Assessment of the Natural Killer...
NEW ADVISORY BRIEF REVEALS WHAT LIFE SCIENCES COMPANIES NEED TO KNOW NOW TO BE PREPARED FOR 2024
Waltham, MA, December 13, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared for 2024” based on highlights presented at the...
PFIZER’S NURTEC RECEIVES TOP RANKING IN 2023 TGAS DIGITAL MARKETING COMPETENCY REPORT
Waltham, MA, November 29, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates...
TRINITY LIFE SCIENCES MAPS OUT INVESTMENT STRATEGIES AND TACTICS TO CALIBRATE A PATIENT-CENTRIC APPROACH IN RARE DISEASE
Waltham, MA, November 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-centric approach in rare disease in its new advisory brief. The brief outlines four pillars...
TRINITY LIFE SCIENCES NAMES FIRST CHIEF TECHNOLOGY OFFICER
Waltham, MA, October 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building...
TRINITY LIFE SCIENCES USES NEW “TETHERED” APPROACH TO INTEGRATE HCP-LEVEL REAL-WORLD DATA AND IMPROVE BRAND SHARE ESTIMATES
Waltham, MA, October 11, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces the first method that incorporates Healthcare Professionals (HCP)-specific real-world behaviors to improve share calibration for forecasting. The method, called “tethering,” uses real-world prescribing...
NEW WHITE PAPER REVEALS THE GOOD, THE BAD AND THE UGLY ON THE JOURNEY TO FULL GLOBALIZATION FOR PHARMA COMMERCIAL OPERATIONS TEAMS
Waltham, MA, October 9, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ white paper “The Globalization Marathon: Is Pharma Commercial Operations Moving to a Full Global Operating Model?” The white...